Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01039 |
| Species: | Homo sapiens |
| Position : | chr7:116474936-116475436 |
| Year: | 2014 |
| Title: | Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 24443471 |
| MONDO: | |
| Tissue: | Inner cell mass |
| Tissue Ontology ID: | UBERON:0000087 |
| Cell Source: | H1 hESCs |
| CVCL ID: | CVCL_9771 |
| Cell Type: | embryonic stem cell |
| Cell Ontology ID: | CL:0002322 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay, TF binding assay |
| High Throughput Method: | ChIP-seq, RNA-seq, 3C-seq, DNase-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR, Western blot |
| Target gene : | MET |
| TF name : | MITF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| MITF | IL6-mediated signaling events | pid | 48 |
| MITF | KitReceptor | netpath | 104 |
| MITF | RANKL | netpath | 84 |
| MITF | Regulation of nuclear beta catenin signaling and target gene transcription | pid | 80 |
| MITF | Regulation of retinoblastoma protein | pid | 67 |
| MITF | Signaling events mediated by Stem cell factor receptor (c-Kit) | pid | 53 |
| MITF | Signaling mediated by p38-alpha and p38-beta | pid | 35 |
| MITF | SUMOylation of transcription factors | reactome | 14 |
| MITF | Melanogenesis | kegg | 100 |
| MITF | Pathways in cancer | kegg | 321 |
| MITF | Melanoma | kegg | 69 |
| MITF | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| MITF | Hs_Kit_receptor_signaling_pathway_WP304_78799 | wikipathways | 46 |
| MITF | Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 | wikipathways | 26 |